PUBLIC COMPANY
saveNoema Pharma AG
updated 13d ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
- phase2A 10-week Efficacy Study of NOE-105 in Childhood Onset Fluency Disorder (Orpheus)
- phase3An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.
- phase2A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause
- phase2Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSC
- —A Study to Validate a Pain Diary for Patient With Trigeminal Neuralgia
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that